What is NTSK's health score?

Netskope Inc (NTSK) has a TradeApes health score of 47 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NTSK's estimated fair value?

Based on our 5-year discounted cash flow model, Netskope Inc's estimated fair value is $8.68 per share, representing a -13.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is NTSK undervalued or overvalued?

Our model currently rates NTSK as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NTSK... Refresh in a moment for the full analysis.

Netskope Inc (NTSK)

Technology Overvalued low mixed

$10.03

Updated: 2026-06-04

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

66 Healthy

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

35 Weak

Est. Fair Value $8.68

DCF Upside -13.4%

Sector Rank #2372 of 7910

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.